08:13 AM EDT, 09/25/2025 (MT Newswires) -- UnitedHealth Group ( UNH ) subsidiary UnitedHealthcare Insurance and Plus Therapeutics' ( PSTV ) CNSide Diagnostics unit have entered into a national coverage deal to offer the the CNSide cerebrospinal fluid tumor cell enumeration laboratory developed test, CNSide said Thursday.

The deal, effective Sept. 15, covers more than 51 million people in the US, the company said.